Pabst Labs is opening a new manufacturing facility and distribution center dedicated to cannabis beverages in Desert Hot Springs, California.
The "cutting edge” facility will allow the company to more than triple its production capabilities.
According to Chuck Barlick, Pabst Labs' director of production, the goal is to leverage over twenty years of beverage manufacturing experience while establishing a standard for quality and efficiency that would set the bar in all cannabis-infused beverages facilities.
On top of its eponymous Pabst Blue Ribbon 10mg High Seltzer, the company also produces Not Your Father's Cannabis-Infused Root Beer and the St. Ides Cannabis product line.
Other brands will be allowed to access the facility through co-packaging relationships to help raise beverage quality and opportunity across the industry.
THC-infused beverages are seeing a 40 percent growth rate, the fastest-growing category in the cannabis industry, according to the Cannabis Beverage Association (CBA).
PBR High Seltzer is one of the top-selling THC-infused carbonated beverages in California.


Can your cat recognise you by scent? New study shows it’s likely
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Debate over H-1B visas shines spotlight on US tech worker shortages
Asian Currencies Stay Rangebound as Yen Firms on Intervention Talk
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Why a ‘rip-off’ degree might be worth the money after all – research study
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Britain has almost 1 million young people not in work or education – here’s what evidence shows can change that
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Oil Prices Slip as U.S.-Iran Talks Ease Middle East Tensions
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 



